Submit Deal

CERTARA INC

HQ - Radnor, Pennsylvania

Summary

Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development.

Deals Overview

Total Deals7

Valued Deals3

Total Value£ 688 M

Avg. Deal Size£ 229 M

Market Context

Senior Management

William F. Feehery
CEO
Patrick F. Smith
President of Integrated Drug Development
Sheila Rocchio
Media Contact

Sort

10 Jun 2021|United Kingdom|Medical Services

Target: INSIGHT MEDICAL WRITING LTD

Bidder: CERTARA INC

4 Service Providers

1 Target | 3 Bidder

13 Dealmakers

1 Target | 12 Bidder

n/a

Value

05 Aug 2021|United States|Software

Target: PINNACLE 21

Bidder: CERTARA INC

10 Service Providers

3 Target | 7 Bidder

23 Dealmakers

1 Target | 22 Bidder

£ 222 M

Value

05 Jan 2022|United States|Pharmaceuticals

Target: INTEGRATED NONCLINICAL DEVELOPMENT SOLUTIONS INC

Bidder: CERTARA INC

3 Service Providers

1 Target | 2 Bidder

5 Dealmakers

1 Target | 4 Bidder

n/a

Value

04 Jan 2023|United States|Software

Target: VYASA ANALYTICS

Bidder: CERTARA INC

3 Service Providers

1 Target | 2 Bidder

5 Dealmakers

2 Target | 3 Bidder

n/a

Value

07 Nov 2022|United States|Software

Target: CERTARA INC

Bidder: ARSENAL CAPITAL PARTNERS INC

8 Service Providers

4 Target | 2 Bidder | 2 Vendor

6 Dealmakers

3 Target | 2 Bidder | 1 Vendor

£ 394 M

Value

13 Dec 2023|United States|Pharmaceuticals

Target: APPLIED BIOMATH

Bidder: CERTARA INC

5 Service Providers

3 Target | 2 Bidder

7 Dealmakers

4 Target | 3 Bidder

n/a

Value

09 Jul 2024|Hungary|Software

Target: CHEMAXON

Bidder: CERTARA INC

6 Service Providers

2 Target | 4 Bidder

6 Dealmakers

1 Target | 5 Bidder

£ 70 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy